5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide

C92H101F8N31O7 — CID 159984935

IUPAC5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
SMILESCn1cc(Nc2nc(N3CC(CC(=O)OC(C)(C)C)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3CC(N)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3CC(NC(=O)c4ccc(C5CC5)cc4)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3C[C@@H](NC(=O)c4ccc(C5CC5)cc4)CC(F)(F)C3)cnc2C(N)=O)cn1.O=C(O)c1ccc(C2CC2)cc1
InChIInChI=1S/C24H26F2N8O2.C24H24F2N8O.C20H25F2N7O2.C14H16F2N8.C10H10O2/c1-33-11-18(9-29-33)30-22-20(21(27)35)28-10-19(32-22)34-12-17(8-24(25,26)13-34)31-23(36)16-6-4-15(5-7-16)14-2-3-14;1-33-12-19(10-29-33)30-22-20(9-27)28-11-21(32-22)34-13-18(8-24(25,26)14-34)31-23(35)17-6-4-16(5-7-17)15-2-3-15;1-19(2,3)31-17(30)5-13-6-20(21,22)12-29(10-13)16-9-24-15(7-23)18(27-16)26-14-8-25-28(4)11-14;1-23-7-10(4-20-23)21-13-11(3-17)19-5-12(22-13)24-6-9(18)2-14(15,16)8-24;11-10(12)9-5-3-8(4-6-9)7-1-2-7/h4-7,9-11,14,17H,2-3,8,12-13H2,1H3,(H2,27,35)(H,30,32)(H,31,36);4-7,10-12,15,18H,2-3,8,13-14H2,1H3,(H,30,32)(H,31,35);8-9,11,13H,5-6,10,12H2,1-4H3,(H,26,27);4-5,7,9H,2,6,8,18H2,1H3,(H,21,22);3-7H,1-2H2,(H,11,12)/t17-;;;;/m0..../s1
InChIKeyOGFGXXDAQQSZNG-UYVPJCOTSA-N
MW1905.01 g/mol
LogP12.20
Rot. Bonds23

About 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide

5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (PubChem CID 159984935) has the molecular formula C92H101F8N31O7 and a molecular weight of 1905.01 g/mol. Its IUPAC name is 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.

Molecular Properties

Compound Name5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
PubChem CID159984935
Molecular FormulaC92H101F8N31O7
Molecular Weight1905.01 g/mol
Exact Mass1903.84
IUPAC Name5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
SMILESCn1cc(Nc2nc(N3CC(CC(=O)OC(C)(C)C)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3CC(N)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3CC(NC(=O)c4ccc(C5CC5)cc4)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3C[C@@H](NC(=O)c4ccc(C5CC5)cc4)CC(F)(F)C3)cnc2C(N)=O)cn1.O=C(O)c1ccc(C2CC2)cc1
InChIInChI=1S/C24H26F2N8O2.C24H24F2N8O.C20H25F2N7O2.C14H16F2N8.C10H10O2/c1-33-11-18(9-29-33)30-22-20(21(27)35)28-10-19(32-22)34-12-17(8-24(25,26)13-34)31-23(36)16-6-4-15(5-7-16)14-2-3-14;1-33-12-19(10-29-33)30-22-20(9-27)28-11-21(32-22)34-13-18(8-24(25,26)14-34)31-23(35)17-6-4-16(5-7-17)15-2-3-15;1-19(2,3)31-17(30)5-13-6-20(21,22)12-29(10-13)16-9-24-15(7-23)18(27-16)26-14-8-25-28(4)11-14;1-23-7-10(4-20-23)21-13-11(3-17)19-5-12(22-13)24-6-9(18)2-14(15,16)8-24;11-10(12)9-5-3-8(4-6-9)7-1-2-7/h4-7,9-11,14,17H,2-3,8,12-13H2,1H3,(H2,27,35)(H,30,32)(H,31,36);4-7,10-12,15,18H,2-3,8,13-14H2,1H3,(H,30,32)(H,31,35);8-9,11,13H,5-6,10,12H2,1-4H3,(H,26,27);4-5,7,9H,2,6,8,18H2,1H3,(H,21,22);3-7H,1-2H2,(H,11,12)/t17-;;;;/m0..../s1
InChIKeyOGFGXXDAQQSZNG-UYVPJCOTSA-N
XLogP12.20
TPSA497.76 Ų
H-Bond Donors9
H-Bond Acceptors34
Rotatable Bonds23
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001905.01
LogP ≤ 512.20
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1034

Analyze 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The IUPAC name of 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (CID 159984935) is 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.
What is the SMILES notation for 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The canonical SMILES for 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide is Cn1cc(Nc2nc(N3CC(CC(=O)OC(C)(C)C)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3CC(N)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3CC(NC(=O)c4ccc(C5CC5)cc4)CC(F)(F)C3)cnc2C#N)cn1.Cn1cc(Nc2nc(N3C[C@@H](NC(=O)c4ccc(C5CC5)cc4)CC(F)(F)C3)cnc2C(N)=O)cn1.O=C(O)c1ccc(C2CC2)cc1.
What is the InChIKey of 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The InChIKey is OGFGXXDAQQSZNG-UYVPJCOTSA-N. The full InChI is InChI=1S/C24H26F2N8O2.C24H24F2N8O.C20H25F2N7O2.C14H16F2N8.C10H10O2/c1-33-11-18(9-29-33)30-22-20(21(27)35)28-10-19(32-22)34-12-17(8-24(25,26)13-34)31-23(36)16-6-4-15(5-7-16)14-2-3-14;1-33-12-19(10-29-33)30-22-20(9-27)28-11-21(32-22)34-13-18(8-24(25,26)14-34)31-23(35)17-6-4-16(5-7-17)15-2-3-15;1-19(2,3)31-17(30)5-13-6-20(21,22)12-29(10-13)16-9-24-15(7-23)18(27-16)26-14-8-25-28(4)11-14;1-23-7-10(4-20-23)21-13-11(3-17)19-5-12(22-13)24-6-9(18)2-14(15,16)8-24;11-10(12)9-5-3-8(4-6-9)7-1-2-7/h4-7,9-11,14,17H,2-3,8,12-13H2,1H3,(H2,27,35)(H,30,32)(H,31,36);4-7,10-12,15,18H,2-3,8,13-14H2,1H3,(H,30,32)(H,31,35);8-9,11,13H,5-6,10,12H2,1-4H3,(H,26,27);4-5,7,9H,2,6,8,18H2,1H3,(H,21,22);3-7H,1-2H2,(H,11,12)/t17-;;;;/m0..../s1.
What are the key properties of 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide has a molecular weight of 1905.01 g/mol, XLogP of 12.20, 23 rotatable bonds, 9 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(5-amino-3,3-difluoropiperidin-1-yl)-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carbonitrile;tert-butyl 2-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]acetate;N-[1-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-5,5-difluoropiperidin-3-yl]-4-cyclopropylbenzamide;4-cyclopropylbenzoic acid;5-[(5S)-5-[(4-cyclopropylbenzoyl)amino]-3,3-difluoropiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide is sourced from PubChem (CID 159984935), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).